Waters Unveils Charge Detection Mass Spectrometry to Speed Next-Generation Biotherapeutics Development

Waters Corporation (NYSE: WAT) has introduced the Waters Xevo Charge Detection Mass Spectrometer (CDMS), a groundbreaking innovation that delivers unmatched measurement and characterization capabilities for mega-mass biomolecules crucial to next-generation…

Read MoreWaters Unveils Charge Detection Mass Spectrometry to Speed Next-Generation Biotherapeutics Development